Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

NEUROCRINE BIOSCIENCES, INC.

(NBIX)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietàFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su NEUROCRINE BIOSCIENCES, INC.
18/10NEUROCRINE BIOSCIENCES: to Present ONGENTYS (opicapone) and INGREZZA (valbenazine) Data a..
14/10Aha moment for markets
14/10ANALYST RECOMMENDATIONS: Asos, Avis Budget, Meritage Homes, Kansas City Southern, UPS...
11/10NEUROCRINE BIOSCIENCES: Announces Conference Call and Webcast of Third Quarter 2021 Finan..
11/10NEUROCRINE BIOSCIENCES: Expands Monumental Moments Program With World-Renowned Artist Jor..
06/10INSIDER SELL: Neurocrine Biosciences
13/09NEUROCRINE BIOSCIENCES: to Present New INGREZZA (valbenazine) and ONGENTYS
10/09NEUROCRINE BIOSCIENCES: to Present New INGREZZA® (valbenazine) and ONGENTYS® (opicapone) ..
10/09Neurocrine Biosciences, Inc. to Present New INGREZZA (Valbenazine) and ONGENTYS Data at..
08/09XENON PHARMACEUTICALS GETS $10 MLN M: Bloomberg
08/09NEUROCRINE BIOSCIENCES: Xenon Pharmaceuticals Announces Collaboration with Neurocrine Bio..
08/09Xenon Pharmaceuticals Inc Announces Collaboration to Develop Treatments for Epilepsy wi..
08/09Xenon Pharmaceuticals Inc. announced that it expects to receive $5.499994 million in fu..
02/09NEUROCRINE BIOSCIENCES: to Present at Upcoming Healthcare Conferences
19/08INSIDER TRENDS: Insider 90-Day Selling Trend Extended at Neurocrine Biosciences
10/08VOYAGER THERAPEUTICS: Transforms pipeline and increases investment in next-generation tra..
05/08NEUROCRINE BIOSCIENCES: Announces Completion of Enrollment in Phase 3 KINECT-HD Study Eva..
05/08Neurocrine Biosciences Announces Completion of Enrollment in Phase 3 KINECT-HD Study Ev..
03/08NEUROCRINE: Q2 Earnings Snapshot
03/08NEUROCRINE BIOSCIENCES: Q2 Non-GAAP Earnings, Revenue Slip
03/08NEUROCRINE BIOSCIENCES: Phase 3 Registrational Program of Valbenazine for the Treatment o..
03/08NEUROCRINE BIOSCIENCES: Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Posts Q2 Revenue $28..
03/08NEUROCRINE BIOSCIENCES: Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Reports Q2 EPS $0.63..
03/08NEUROCRINE BIOSCIENCES: Management's Discussion and Analysis of Financial Condition and R..
03/08NEUROCRINE BIOSCIENCES INC: Results of Operations and Financial Condition (form 8-K)
03/08Neurocrine Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June..
03/08NEUROCRINE BIOSCIENCES: Reports Second Quarter 2021 Financial Results
03/08EARNINGS REACTION HISTORY: Neurocrine Biosciences, 50.0% Follow-Through Indicator, 4.6% S..
31/07NEUROCRINE BIOSCIENCES: NBIX) Insider Makes Significant Share Sale
29/07INSIDER TRENDS: Selling By Insiders Lingers at Neurocrine Biosciences
27/07Idorsia schliesst erstes Halbjahr 2021 etwas besser als erwartet ab
27/07PRESS RELEASE: Idorsia announces financial -2-
27/07PRESS RELEASE: Idorsia announces financial results for the first half 2021 -- Building mo..
27/07GlobeNewswire/Idorsia gibt Finanzergebnisse für -3-
27/07GlobeNewswire/Idorsia gibt Finanzergebnisse für -2-
27/07GlobeNewswire/Idorsia gibt Finanzergebnisse für das erste Halbjahr 2021 bekannt -- Entw..
23/07DGAP-NEWS: Il settore delle biotecnologie -2-
23/07DGAP-NEWS: Biotechbranche mit solidem 2. Quartal -2-
23/07PRESS RELEASE: Solid second quarter for the -2-
22/07NEUROCRINE BIOSCIENCES/THE HARRIS PO: 8 in 10 Americans Will Always Prefer In-Person Doct..
19/07NEUROCRINE BIOSCIENCES: Announces Conference Call and Webcast of Second Quarter 2021 Fina..
08/07NEUROCRINE BIOSCIENCES: to Participate at the William Blair Biotech Focus Conference
25/06NEUROCRINE BIOSCIENCES, INC.(NASDAQG: NBIX) dropped from Russell 1000 Defensive Index
25/06NEUROCRINE BIOSCIENCES, INC.(NASDAQG: NBIX) dropped from Russell 1000 Growth-Defensive In..
16/06NEUROCRINE BIOSCIENCES: Insider Makes Significant Stock Sells in Neurocrine Biosciences (..
15/06INSIDER TRENDS: Insider Prolongs 90-Day Selling Trend at Neurocrine Biosciences
01/06NEUROCRINE BIOSCIENCES: to Present at the Goldman Sachs 42nd Annual Global Healthcare Con..
21/05NEUROCRINE BIOSCIENCES INC: Submission of Matters to a Vote of Security Holders (form 8-K..
17/05POLYCYSTIC OVARY SYNDROME PIPELINE: Emerging Therapies and Key pharma players involved by..
11/05NEUROCRINE BIOSCIENCES: to Present at the 2021 RBC Global Healthcare Conference
05/05NEUROCRINE: Q1 Earnings Snapshot
05/05NEUROCRINE BIOSCIENCES: Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Reports Q1 EPS $0.49..
05/05NEUROCRINE BIOSCIENCES: Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Posts Q1 Revenue $23..
05/05NEUROCRINE BIOSCIENCES: Management's Discussion and Analysis of Financial Condition and R..
05/05NEUROCRINE BIOSCIENCES INC: Results of Operations and Financial Condition (form 8-K)
05/05NEUROCRINE BIOSCIENCES: Reports First Quarter 2021 Financial Results
05/05Neurocrine Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March..
05/05EARNINGS REACTION HISTORY: Neurocrine Biosciences, 55.6% Follow-Through Indicator, 5.6% S..
04/05NEUROCRINE BIOSCIENCES: to Present at the Bank of America 2021 Healthcare Conference
04/05NEUROCRINE BIOSCIENCES: Supports Mental Health Month and Tardive Dyskinesia Awareness Wee..
26/04Sentia Medical Sciences Inc. and Neurocrine Biosciences, Inc. Enter into Strategic Coll..
23/04DGAP-NEWS: BB BIOTECH AG: Le efficaci campagne di -2-
22/04Idorsia a réduit ses pertes au 1er trimestre
22/04Idorsia a réduit sa perte au 1er trimestre
22/04Idorsia schliesst erstes Quartal 2021 besser als erwartet ab
22/04GlobeNewswire/Idorsia gibt Finanzergebnisse für -3-
22/04GlobeNewswire/Idorsia gibt Finanzergebnisse für das erste Quartal 2021 bekannt -- marka..
22/04PRESS RELEASE: Idorsia announces financial -2-
22/04PRESS RELEASE: Idorsia announces financial results for the first quarter 2021 -- substant..
19/04Neurocrine Biosciences Announces Appointment of Johanna Mercier to Board of Directors
16/04NEUROCRINE BIOSCIENCES INC: Change in Directors or Principal Officers (form 8-K)
16/04Neurocrine Biosciences, Inc. Appoints Johanna Mercier as Member of the Board
16/04NEUROCRINE BIOSCIENCES: Announces Appointment of Johanna Mercier to Board of Directors
14/04NEUROCRINE BIOSCIENCES: Announces Conference Call and Webcast of First Quarter 2021 Finan..
09/04NEUROCRINE BIOSCIENCES: to Present Data from its Neurology Portfolio at the American Acad..
1  2  3  4  5  6  7  8  9  10Pross.
Prossimo evento su NEUROCRINE BIOSCIENCES, INC.
01/11/21